#personalized-medicine

#personalized-medicine

Probiotic formulations have evolved to target specific health needs based on individual strain characteristics.

The Mayo Clinic's fecal waste biobank aims to personalize cancer treatment by studying the microbiome's impact on patient responses to medications.

CRISPR technology provides a personalized treatment option for patients with life-threatening genetic disorders.

CRISPR technology shows potential in customized gene therapy for rare diseases, specifically in treating a patient with liver mutations.

KJ Muldoon was diagnosed with a severe genetic disorder, CPS 1 deficiency, leading to groundbreaking gene-editing treatment efforts.

CRISPR therapy shows promise for treating ultra-rare genetic diseases, demonstrated by KJ Muldoon, the first recipient of tailored gene-editing treatment.

AI-designed drugs could enter clinical trials by the end of the year, potentially transforming drug development.

A new TIL therapy shows promise for treating metastatic gastrointestinal cancers and may extend to other solid tumors.

Cancer cases and deaths are projected to increase significantly by 2040 despite advancements in treatment.

Precision medicine offers personalized cancer treatment by targeting specific mutations, maximizing effectiveness, and minimizing side effects.

Identify modifiable targets and mechanisms to improve CNS-related outcomes in individuals with HIV, enhancing their quality of life and functional capacity.

mRNA technology's success in COVID vaccines is paving the way for personalized cancer vaccines.